Company news

PharmAla Biotech Holdings, Inc. news in 2025

PharmAla Biotech Holdings, Inc.'s news releases, calls and decks from 2025, newest first.

View company

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

December 24, 2025

PharmAla Biotech Australia Contracts with UK-based CDMO for Manufacture of ALA-002 Drug Substance

December 15, 2025

PharmAla Biotech Completes Release Testing on Australian-Made LaNeo Capsules

December 10, 2025

PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital

November 3, 2025

PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists

October 8, 2025

PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins

October 2, 2025

PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand

September 25, 2025

PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus

September 19, 2025

PharmAla Completes Import of LaNeo MDMA for US Distribution

September 8, 2025

PharmAla Incorporates Australian Entity for Clinical Research

September 3, 2025

PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License

August 7, 2025

PharmAla Issues Q3 Financial Statements

July 25, 2025

PharmAla Files Preliminary Base Shelf Prospectus

June 20, 2025

PharmAla Completes Shipment of LaNeo™ MDMA to Yale University, Provides Investor Update

June 3, 2025

PharmAla Biotech Warns Against Fake Products Claiming to be Made by PharmAla

May 30, 2025

PharmAla Biotech Launches Phenesafe AI Drug Discovery Platform for Novel Phenethylamines

May 15, 2025

PharmAla Issues Q2 Financial Statements

April 30, 2025

PharmAla Contracts with Partner to Act as US Distributor

March 24, 2025

PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington

March 21, 2025

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

March 10, 2025

PharmAla Completes Shipment of LaNeo™ MDMA to UCLA for Schizophrenia Study

March 3, 2025

PharmAla to supply STRONG STAR at UT Health San Antonio, with novel dosage form of LaNeo™ MDMA

February 27, 2025